These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9593168)

  • 1. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
    Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
    Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.
    Vakulenko SB; Geryk B; Kotra LP; Mobashery S; Lerner SA
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1542-8. PubMed ID: 9660980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
    Li M; Conklin BC; Taracila MA; Hutton RA; Skalweit MJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5678-86. PubMed ID: 22908166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
    Randegger CC; Hächler H
    J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases.
    Nüesch-Inderbinen MT; Hächler H; Kayser FH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1726-30. PubMed ID: 7486909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    FEMS Microbiol Lett; 1998 Mar; 160(1):49-54. PubMed ID: 9495011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Asp104 in the SHV beta-lactamase.
    Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A237T as a modulating mutation in naturally occurring extended-spectrum TEM-type beta-lactamases.
    Blázquez J; Negri MC; Morosini MI; Gómez-Gómez JM; Baquero F
    Antimicrob Agents Chemother; 1998 May; 42(5):1042-4. PubMed ID: 9593123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
    Hujer AM; Hujer KM; Bonomo RA
    Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
    Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
    Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.
    Thomson JM; Distler AM; Prati F; Bonomo RA
    J Biol Chem; 2006 Sep; 281(36):26734-44. PubMed ID: 16803899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
    Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.